| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $103.5M | +91.7% |
| Cost of Revenue | $59.2M | +1.7% |
| Gross Profit | $44.4M | +1167.2% |
| R&D Expense | $9.2M | -6.2% |
| SG&A Expense | $22.2M | +5.3% |
| Operating Income | -$4.5M | +91.3% |
| Pre-tax Income | -$1.3M | +98.0% |
| Income Tax | $603K | +485.4% |
| Net Income | -$1.9M | +97.0% |
| EPS (Basic) | -$0.03 | +97.1% |
| EPS (Diluted) | -$0.03 | +97.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.7M | -34.7% |
| Short-term Investments | $8.2M | +0.0% |
| Accounts Receivable | $13.9M | +74.2% |
| Inventory | $31.3M | +42.2% |
| Current Assets | $58.0M | +8.6% |
| Total Assets | $78.0M | +7.0% |
| Current Liabilities | $38.8M | +126.6% |
| Long-term Debt |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.3M | +183.4% |
| Capital Expenditures | $642K | -50.1% |
| Investing Cash Flow | $22.6M | +14.5% |
| Financing Cash Flow | -$37.0M | — |
| Free Cash Flow | $9.7M | +170.8% |
| $0 |
| -100.0% |
| Total Liabilities | $50.4M | -21.9% |
| Stockholders' Equity | $27.6M | +229.4% |